You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金河生物(002688.SZ):擬放棄控股子公司金河佑本的增資優先認購權
格隆匯 11-19 21:18

格隆匯11月19日丨金河生物(002688.SZ)公佈,公司控股子公司金河佑本生物製品有限公司(“金河佑本”)目前註冊資本為人民幣10.2億元,擬增加註冊資本人民幣1億元,公司關聯方內蒙古金河控股有限公司(“金河控股”)、呼和浩特金佑天成管理諮詢中心(有限合夥)(“金佑天成”)及非關聯方王家福等9名自然人擬以人民幣1億元的價格認購金河佑本上述增加的註冊資本,增資款項擬全部用於與有關單位合作建設實驗室的合作項目和補充托克托縣動物疫苗生產基地建設項目所需流動資金。

本次增資完成後,金河佑本的註冊資本變更為人民幣11.2億元。公司擬放棄本次增資優先認購權,交易各方已於2021年11月19日簽署《增資協議》。

本次增資完成後,公司對金河佑本的持股比例由94%降至85.61%,公司仍為其控股股東並繼續將其納入合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account